An HIV vaccine candidate trialed in Sub-Saharan Africa offers no substantial protection against HIV infection among young women, the study
Read more
Home »
Dolutegravir and ritonavir-boosted darunavir are equally effective second-line treatments for HIV-1, even for patients with resistance to nucleoside reverse-transcriptase inhibitors
Read more
A trailblazing HIV research center is being set up in the UK to address health inequalities and improve quality of
Read more
In a new feature in the New England Journal of Medicine, Michael Saag, M.D., professor with the University of Alabama
Read more
Annual cases of sexually transmitted infections (STIs) in the United States jumped for the sixth year in a row in
Read more
Inflammation in the body has been linked to the intensity of tobacco smoking among people with HIV, according to a
Read more
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), resides in mucous membranes, making
Read more
HIV self-testing could reduce the time between HIV infection and HIV diagnosis amongst trans people when compared to standard testing
Read more
Prompted by the need to improve conventional treatments for people infected with the human immunodeficiency virus (HIV-1), a team from
Read more
Treatment for HIV has improved tremendously over the past 30 years; once a death sentence, the disease is now a
Read more